This was published 4 years ago
Heath-related stocks lead the way at halfway mark
By John Collett
Angie Ellis, of 80 20 Investments, a regular winner of the Shares Race, has shot to first place in week three of the contest.
Her $10,000 investment in Antara Lifesciences, which develops and commercialises products for gastrointestinal health, is now worth $15,358, up from $13,269 last week. It is the second-best performing stock pick of all contestants.
Ellis and Dan Sliver, co-CEO of Stake, hold Paradigm Biopharmaceuticals, with their original $10,000 investment in the inflammation treatment company worth $13,258.
Ellis' portfolio is worth now $111,574, with Richard Hemming, of Under The Radar Report, in second with a portfolio value of $107,849, just ahead of Dominic Powell, retail reporter for the SMH&Age, on $107,439.
Cann Group remains the best performer of all the stock tips, with Powell's original $10,000 investment in the medicinal cannabis stock now worth $16,000, down from $17,824 last week.
Chris Conway, of the daily stock market newsletter Marcus Today, who is in fifth place, holds PolyNovo, with his original $10,000 investment in the medical technology company now worth $14,604, up from $14,010 last week.
The sharemarket, as measured by the S&P/ASX 200 index, finished the week more than 1 per cent lower at 7,006 points on Thursday, the day each week that the competition ends.
The Shares Race is a fantasy shares game that runs for six weeks. Players start with $100,000, divided evenly across 10 stocks. Their progress is reported weekly.